Your browser doesn't support javascript.
loading
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
McLouth, Laurie E; Zheng, Yue; Smith, Stephanie; Hodi, F Stephen; Rao, Uma N; Cohen, Gary I; Amatruda, Thomas T; Dakhil, Shaker R; Curti, Brendan D; Nakhoul, Ibrahim; Chandana, Sreenivasa R; Bane, Charles L; Marinier, David E; Lee, Sandra J; Sondak, Vernon K; Kirkwood, John M; Tarhini, Ahmad A; Wagner, Lynne I.
  • McLouth LE; Department of Behavioral Science, College of Medicine, Markey Cancer Center, University of Kentucky, 467 Healthy Kentucky Research Building, 760 Press Avenue, Lexington, KY, 40508, USA. Laurie.mclouth@uky.edu.
  • Zheng Y; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Smith S; Nancy N. and J.C. Lewis Cancer and Research Pavilion, St. Joseph's/Candler, Savannah, GA, USA.
  • Hodi FS; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Rao UN; Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, MA, USA.
  • Cohen GI; University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Amatruda TT; Greater Baltimore Medical Center, Baltimore, MD, USA.
  • Dakhil SR; Minnesota Oncology, Fridley, MN, USA.
  • Curti BD; Ascension Via Christi Hospitals, Wichita, KS, USA.
  • Nakhoul I; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA.
  • Chandana SR; Regional Cancer Center at Indian Path Community Hospital, Kingsport, TN, USA.
  • Bane CL; Cancer and Hematology Centers of Western Michigan/Cancer Research Consortium of West Michigan NCORP, Grand Rapids, MI, USA.
  • Marinier DE; Good Samaritan Hospital-Dayton, Dayton, OH, USA.
  • Lee SJ; Gundersen Health System, La Crosse, WI, USA.
  • Sondak VK; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Kirkwood JM; Moffitt Cancer Center, Tampa, FL, USA.
  • Tarhini AA; University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Wagner LI; Moffitt Cancer Center, Tampa, FL, USA.
Qual Life Res ; 32(1): 183-196, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36029412

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Melanoma Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Melanoma Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article